Conmed Corp. Forecast, price target & analysts
Conmed Corp. Target price 2025 - Analyst rating & recommendation
Conmed Corp. Classifications & Recommendation:
Conmed Corp. Price Target
| Target Price | $77.29 |
| Price | $57.90 |
| Potential |
33.48%
register free of charge
|
| Number of Estimates | 7 |
|
7 Analysts have issued a price target Conmed Corp. 2026 .
The average Conmed Corp. target price is $77.29.
This is
33.48%
register free of charge
$91.00
57.17%
register free of charge
$70.00
20.90%
register free of charge
|
|
| A rating was issued by 7 analysts: 3 Analysts recommend Conmed Corp. to buy, 4 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Conmed Corp. stock has an average upside potential 2026 of
33.48%
register free of charge
|
Sales and Margin forecast 2025, 2026 & 2027
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Billion $ | 1.30 | 1.36 |
| 4.98% | 4.19% | |
| EBITDA Margin | 16.54% | 20.22% |
| 12.69% | 22.22% | |
| Net Margin | 10.08% | 9.50% |
| 98.45% | 5.76% |
7 Analysts have issued a sales forecast Conmed Corp. 2025 . The average Conmed Corp. sales estimate is
This results in the following potential growth metrics:
6 Analysts have issued an Conmed Corp. EBITDA forecast 2025. The average Conmed Corp. EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
4 Conmed Corp. Analysts have issued a net profit forecast 2025. The average Conmed Corp. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 & 2027
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | 4.25 | 4.18 |
| 108.33% | 1.65% | |
| P/E | 13.87 | |
| EV/Sales | 2.00 |
4 Analysts have issued a Conmed Corp. forecast for earnings per share. The average Conmed Corp. EPS is
This results in the following potential growth metrics and future valuations:
Current Conmed Corp. Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| JP Morgan |
Locked
➜
Locked
|
Locked | Feb 06 2025 |
| Needham |
Locked
➜
Locked
|
Locked | Feb 06 2025 |
| Stifel |
Locked
➜
Locked
|
Locked | Feb 06 2025 |
| Wells Fargo |
Locked
➜
Locked
|
Locked | Feb 06 2025 |
| Needham |
Locked
➜
Locked
|
Locked | Oct 31 2024 |
| Needham |
Locked
➜
Locked
|
Locked | Oct 04 2024 |
| Analyst Rating | Date |
|---|---|
|
Locked
JP Morgan:
Locked
➜
Locked
|
Feb 06 2025 |
|
Locked
Needham:
Locked
➜
Locked
|
Feb 06 2025 |
|
Locked
Stifel:
Locked
➜
Locked
|
Feb 06 2025 |
|
Locked
Wells Fargo:
Locked
➜
Locked
|
Feb 06 2025 |
|
Locked
Needham:
Locked
➜
Locked
|
Oct 31 2024 |
|
Locked
Needham:
Locked
➜
Locked
|
Oct 04 2024 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
